Bringing DNA vaccines closer to commercial use

IDrugs

Volumn 12, Issue 10, 2009, Pages 642-647

  Carvalho, J A ^a   Prazeres, D Mf ^a   Monteiro, G A ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

'DNA'; APEX IHN; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; LIFETIDE; LIPOSOME; MELANOMA VACCINE; UNCLASSIFIED DRUG; VACCINE; VCR WNVDNA017 00 VP VACCINE; VRC HIVDNA016 00 VP VACCINE; WEST NILE INNOVATOR DNA VACCINE;

AFRICAN TRYPANOSOMIASIS; CHAGAS DISEASE; CLINICAL EVALUATION; CLINICAL TRIAL; COMMERCIAL PHENOMENA; COMPARATIVE STUDY; DNA IMMUNIZATION; DNA VECTOR; DRUG DELIVERY SYSTEM; FETUS WASTAGE; GENE DELIVERY SYSTEM; GENETIC VARIABILITY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS; INFLUENZA; INFLUENZA VIRUS; LEISHMANIA; LEISHMANIASIS; LIMB ISCHEMIA; LUNG NON SMALL CELL CANCER; MALARIA; MELANOMA; MODEL; MULTIPLE SCLEROSIS; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROPHYLAXIS; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; TECHNOLOGY; TRYPANOSOMA CRUZI; TUBERCULOSIS; VETERINARY MEDICINE; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ANIMALS; CLINICAL TRIALS AS TOPIC; COMMERCE; DRUG DISCOVERY; HUMANS; TECHNOLOGY, PHARMACEUTICAL; VACCINES, DNA;

EID: 70349759753     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Diogo MM, Queiroz JA, Monteiro GA, Martins SA, Ferreira GN, Prazeres DM: Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography. Biotechnol Bioeng (2000) 68(5):576-583.
2. Robinson HL, Hunt LA, Webster RG: Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. Vaccine (1993) 11(9):957-960.
3. Dumonteil E: DNA vaccines against protozoan parasites: Advances and challenges. J Biomed Biotechnol (2007) 2007 (6):90520.
4. Rice J, Ottensmeier CH, Stevenson FK: DNA vaccines: Precision tools for activating effective immunity against cancer. Nat Rev Cancer (2008) 8(2):108-120.
5. Rappuoli R: Bridging the knowledge gaps in vaccine design. Nat Biotechnol (2007) 25(12):1361-1366.
6. Kutzler MA, Weiner DB: DNA vaccines: Ready for prime time? Nat Rev Genet (2008) 9(10):776-788.
7. Sheridan C: The business of making vaccines. Nat Biotech (2005) 23(11):1359-1366.
8. Guidance for Industry: Considerations for plasmid DNA vaccines for infectious disease indications: Food and Drug Administration, Silver Spring, MD, USA (2007). www.fda.gov/downloads/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm091968.pdf